Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Access to Care

New York Expands Provider Access with Residency and Fellowship Programs

Effective immediately, 20,000 residents and fellowship physicians in ACGME programs can now treat injured workers, under faculty supervision.

Read More →

May 19, 2025

Worker Classification

Oklahoma Employers Can Now Exclude Unpaid Temp Workers from Workers’ Comp

Unpaid temp workers who are working for experience will no longer be considered employees entitled to workers’ comp coverage.

Read More →

May 19, 2025

Presumptions

Connecticut Updates Cancer Coverage for Firefighters

In addition to now covering skin cancer, the state will handle cancer cases differently and adjust the five-year service requirement.

Read More →

May 19, 2025

Marijuana Training Opportunity

ACOEM Webinar to Cover Cannabis Guidelines

The May 21st webinar will examine medical literature on cannabis for acute, chronic, and postoperative pain.

Read More →

May 19, 2025

Cyber Risk Technology

Congressional Budget Bill Would Place a 10-Year Ban on State AI Regulations

If passed with this recent amendment, the bill would prevent the enforcement of laws on AI models and automated decision systems.

Read More →

May 19, 2025

Worker Safety

Vermont Proposes Worker Safety Bill for Extreme Temperatures

The bill would recognize temperatures above 80°F or below 60°F as extreme temperatures, with exemptions for short-term exposure.

Read More →

May 12, 2025

Worker Safety

Michigan Introduces Infectious Disease Bill

The bill proposes an infectious disease worker safety commission to determine best practices during an emergency declared due to infectious disease.

Read More →

May 12, 2025

Cost Containment

Louisiana Fee Schedule Bill Passes House, Moves to Senate

If enacted, House Bill 117 would trigger the first update to the Louisiana workers’ comp fee schedule in 30 years.

Read More →

May 12, 2025

Mental Health Psychedelics

New Mexico Enacts Psychedelic Therapy Bill

Senate Bill 219 allows for psilocybin therapy for the treatment of PTSD, treatment-resistant depression, and more.

Read More →

May 12, 2025

« Previous 1 … 30 31 32 33 34 … 54 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.